Ipratropoium Bromide contains not less than 99.0% and not more than 100.5% of Ipratropoium bromide (C20H30BrNO3‧H2O), calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

溴化依普托品
Ipratropium Bromide

• 申請商: 新雙隆生技股份有限公司
• 適應症: 慢性阻塞性支氣管炎、支氣管氣喘
• 發證日期: 2017-12-15